MorphoSys AG has announced plans to sell its service business, AbD Serotec, to Bio-Rad Laboratories Inc for €53 million in cash. The divestment will enable the German company to focus on its therapeutic antibody business. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
